NCT00447005View on ClinicalTrials.gov

Study Of AG-013736 (Axitinib) In Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Carcinoma

Interventions

DRUG

Axitinib (AG-013736)

AG-013736 5mg twice daily \[BID\]

Trial Locations (1)

Unknown

Pfizer Investigational Site, Kashiwa

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY